Ticker

Analyst Price Targets — STEX

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
November 25, 2025 12:25 pmNeedham$12.00$4.16TheFly Streamex initiated with a Buy at Needham

Latest News for STEX

Head-To-Head Review: MiniMed Group (NASDAQ:MMED) & Biosig Technologies (NASDAQ:STEX)

MiniMed Group (NASDAQ: MMED - Get Free Report) and Biosig Technologies (NASDAQ: STEX - Get Free Report) are both manufacturing companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. Analyst Ratings This is a breakdown of recent

Defense World • Apr 19, 2026
Streamex Corp. Announces Webcast Details for Wednesday, April 8 Earnings and Corporate Update Presentation

WINTER PARK, Fla., April 06, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced webcast details for its earnings and corporate update presentation to be held on Wednesday, April 8, 2026, at 4:30 p.m. EDT.

GlobeNewsWire • Apr 6, 2026
Streamex Corp. Clarifies and Refutes Inaccurate Claims Regarding Lock-Up Agreements; Co-Founders Morgan Lekstrom & Henry McPhie Enter into Voluntary 1 Year Lock-Up Agreements

WINTER PARK, Fla., March 27, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX) today issued a statement to clarify and formally refute a series of third-party posts attributed to S&P Capital IQ and displayed on MarketScreener on March 23, 2026, which referenced the purported expiration on March 24, 2026 of certain lock-up agreements.

GlobeNewsWire • Mar 27, 2026
Head to Head Contrast: Longevity Health (NASDAQ:XAGE) & Biosig Technologies (NASDAQ:STEX)

Longevity Health (NASDAQ: XAGE - Get Free Report) and Biosig Technologies (NASDAQ: STEX - Get Free Report) are both small-cap manufacturing companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, profitability, analyst recommendations, institutional ownership and dividends. Analyst Recommendations This is a breakdown of

Defense World • Mar 27, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for STEX.

No House trades found for STEX.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top